Chemical Characterization of Novel Natural Products from the Roots of Asian Rice ( Oryza sativa) that Control Adipocyte and Osteoblast Differentiation.
Kang HR., Yun HS., Lee TK., Lee S., Kim SH., Moon E.
Animal Study, published in J Agric Food Chem (2018) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- J Agric Food Chem (2018)
- Country
- United States
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 29444566
- DOI
- 10.1021/acs.jafc.7b05030
Abstract (original English)
Oryza sativa L. is consumed globally as a staple food, and its roots have been used as a Korean and Chinese medical supplement for protection of the stomach and lungs and for amelioration of vomiting and fever. In our continuing search for biologically effective metabolites from Korean natural materials, we found that an EtOH extract of O. sativa root reciprocally regulated adipocyte and osteoblast differentiation. Chemical analysis of the EtOH extract using a bioassay-guided fractionation protocol led to the isolation and determination of two novel lignans, oryzativols A and B, responsible for these regulatory activities. Using 1D and 2D nuclear magnetic resonance spectroscopic analyses, high-resolution mass spectrometry, and circular dichroism analysis, the structures of the novel compounds were elucidated. We examined their effects on the regulation of mesenchymal stem cell differentiation. Treatment with oryzativol A in the human mesenchymal cell line C3H10T1/2 suppressed gene expression of peroxisome proliferator activated receptor γ, which resulted in a reduction in adipogenesis. Oryzativol A also enhanced the expression of Runx2 and cellular differentiation into osteoblasts in the same mesenchymal stem cell line.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.